RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Dianqing Sun to Mycobacterium tuberculosis

This is a "connection" page, showing publications Dianqing Sun has written about Mycobacterium tuberculosis.
Connection Strength

0.878
  1. Prior AM, Sun D. Solid-Phase Synthesis of Wollamide Cyclohexapeptide Analogs. Methods Mol Biol. 2020; 2103:175-187.
    View in: PubMed
    Score: 0.163
  2. Yu X, Zhang M, Annamalai T, Bansod P, Narula G, Tse-Dinh YC, Sun D. Synthesis, evaluation, and CoMFA study of fluoroquinophenoxazine derivatives as bacterial topoisomerase IA inhibitors. Eur J Med Chem. 2017 Jan 05; 125:515-527.
    View in: PubMed
    Score: 0.130
  3. Lee RE, Hurdle JG, Liu J, Bruhn DF, Matt T, Scherman MS, Vaddady PK, Zheng Z, Qi J, Akbergenov R, Das S, Madhura DB, Rathi C, Trivedi A, Villellas C, Lee RB, Waidyarachchi SL, Sun D, McNeil MR, Ainsa JA, Boshoff HI, Gonzalez-Juarrero M, Meibohm B, B?ttger EC, Lenaerts AJ. Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux. Nat Med. 2014 Feb; 20(2):152-158.
    View in: PubMed
    Score: 0.108
  4. Shen L, Maddox MM, Adhikari S, Bruhn DF, Kumar M, Lee RE, Hurdle JG, Lee RE, Sun D. Syntheses and evaluation of macrocyclic engelhardione analogs as antitubercular and antibacterial agents. J Antibiot (Tokyo). 2013 Jun; 66(6):319-25.
    View in: PubMed
    Score: 0.102
  5. Sun D, Hurdle JG, Lee R, Lee R, Cushman M, Pezzuto JM. Evaluation of flavonoid and resveratrol chemical libraries reveals abyssinone II as a promising antibacterial lead. ChemMedChem. 2012 Sep; 7(9):1541-5.
    View in: PubMed
    Score: 0.097
  6. Brown JR, North EJ, Hurdle JG, Morisseau C, Scarborough JS, Sun D, Kordul?kov? J, Scherman MS, Jones V, Grzegorzewicz A, Crew RM, Jackson M, McNeil MR, Lee RE. The structure-activity relationship of urea derivatives as anti-tuberculosis agents. Bioorg Med Chem. 2011 Sep 15; 19(18):5585-95.
    View in: PubMed
    Score: 0.091
  7. Sivendran S, Jones V, Sun D, Wang Y, Grzegorzewicz AE, Scherman MS, Napper AD, McCammon JA, Lee RE, Diamond SL, McNeil M. Identification of triazinoindol-benzimidazolones as nanomolar inhibitors of the Mycobacterium tuberculosis enzyme TDP-6-deoxy-d-xylo-4-hexopyranosid-4-ulose 3,5-epimerase (RmlC). Bioorg Med Chem. 2010 Jan 15; 18(2):896-908.
    View in: PubMed
    Score: 0.081
  8. Sun D, Jones V, Carson EI, Lee RE, Scherman MS, McNeil MR, Lee RE. Solid-phase synthesis and biological evaluation of a uridinyl branched peptide urea library. Bioorg Med Chem Lett. 2007 Dec 15; 17(24):6899-904.
    View in: PubMed
    Score: 0.070
  9. Sun D, Lee RB, Tangallapally RP, Lee RE. Synthesis, optimization and structure-activity relationships of 3,5-disubstituted isoxazolines as new anti-tuberculosis agents. Eur J Med Chem. 2009 Feb; 44(2):460-72.
    View in: PubMed
    Score: 0.018
  10. Tangallapally RP, Sun D, Budha N, Lee RE, Lenaerts AJ, Meibohm B, Lee RE. Discovery of novel isoxazolines as anti-tuberculosis agents. Bioorg Med Chem Lett. 2007 Dec 01; 17(23):6638-42.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support